Sleep and respiratory product maker ResMed has acquired Denmark’s Maribo Medico, a privately held provider of sleep-disordered breathing medical devices and accessories that specializes in the education, diagnosis, treatment and management of sleep-disordered breathing and respiratory diseases.
Maribo Medico has been ResMed’s exclusive distribution partner in Denmark for longer than 15 years, and under the deal, Maribo Medico employees, including the company’s CEO Mette Toxværd Larsen, will continue on in their current roles.
Together, the companies aim to serve an estimated 750,000 Danes with obstructive sleep apnea (OSA) and 400,000 people suffering from chronic obstructive pulmonary disease (COPD) in the country.
“Maribo Medico’s strong team and talented leadership, their market reputation, and their commitment to research and education for sleep and respiratory medicine have helped tens of thousands of people in Denmark who suffer from sleep-disordered breathing and chronic obstructive pulmonary disease,” said Anne Reiser, president of ResMed EMEA-APAC. “Maribo and ResMed together will accelerate growth while improving patient quality-of-life and reducing total healthcare system costs in Denmark. This combination is part of our global goal of improving 20 million lives by 2020.”
“We are very happy to join with ResMed to help even more people who suffer from sleep-disordered breathing or chronic respiratory diseases,” Toxværd Larsen said. “We’ve had a strong and fruitful partnership with ResMed for more than 15 years, and now we will leverage their global strength to improve many more lives in Denmark, building our position in respiratory care and digital, tele-monitoring solutions.”